Division of HIV, ID and Global Medicine

Active Projects: 10

Project Investigator All Organizations Start date End date
Mentoring translational scientists in international infectious disease research Bryan Greenhouse, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal Grant Dorsey, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV Judith Hahn, PhD, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Host genetic predictors of plasma IL-1b levels and pharmacogenomics of in vivo IL-1b blockade during treated HIV disease Sulggi Lee, MD Center for AIDS Research (CFAR), Division of HIV, ID and Global Medicine
GenMoz P. falciparum genomic intelligence in Mozambique Bryan Greenhouse, MD Division of HIV, ID and Global Medicine
Biomarkers for Alcohol/HIV Research (BAHR) Study Judith Hahn, PhD, MD Division of HIV, ID and Global Medicine
Biomarkers for Alcohol/HIV Research (BAHR) Study Judith Hahn, PhD, MD Division of HIV, ID and Global Medicine
Drivers of strain-specific and strain-transcendent antimalarial immunity in childhood Bryan Greenhouse, MD Division of HIV, ID and Global Medicine
Quantum: Quantifying the spread of P. falciparum malaria Bryan Greenhouse, MD Division of HIV, ID and Global Medicine, Department of Radiology and Biomedical Imaging

Archived Projects: 377

Project Investigator All Organizations Start date End date
Immediate Salvage Therapy w/ Combination ART plus T-20 vs. A 16 Week Structured Treatment Interruption Followed by Combination Therapy plus T-20 Steven Deeks, MD Division of HIV, ID and Global Medicine
PCP OPW Specimens Laurence Huang, MD Division of HIV, ID and Global Medicine
Women's Specialty Program Infrastructure Support Contract Ruth Greenblatt, MD Division of HIV, ID and Global Medicine
Interruption of Enfuvirtide in Patients Experiencing an Incomplete Virologic Response to Enfuvirtide-Based Combination Antiretroviral Regimen Steven Deeks, MD Division of HIV, ID and Global Medicine
Crossing Boundaries: Continuity of Medical Care for Incarcerated Adults Jacqueline Tulsky, MD Division of HIV, ID and Global Medicine
International AIDS Research and Prevention Diane Havlir, MD Division of HIV, ID and Global Medicine
Behavioral, Basic, and Clinical Studies of PEP Division of HIV, ID and Global Medicine
Evaluate Serum-Based Assay for Pneumocystis Pneumonia Diagnosis Laurence Huang, MD Division of HIV, ID and Global Medicine
UCSF HIV/AIDS Management Training Programs Diane Havlir, MD Division of HIV, ID and Global Medicine
Chicago Women's Interagency HIV Study Consortium (WIHS) Biostatistical Data Analyses Ruth Greenblatt, MD Division of HIV, ID and Global Medicine, Department of Clinical Pharmacy, AIDS Research Institute
Primary Care Services- Non Severe Need - Ward 86 Division of HIV, ID and Global Medicine, AIDS Research Institute
WIHS Treatment Exposure and Viral Rebound Study / AIDS Research Ruth Greenblatt, MD Division of HIV, ID and Global Medicine
Treatment Intensification for Drug-Resistant HIV Steven Deeks, MD Division of HIV, ID and Global Medicine
The Use of Nelfinavir During Acute or Early HIV Infection - Safety, Tolerability, Durablilty and Resistance Division of HIV, ID and Global Medicine, AIDS Research Institute
A Clinical Trial of DOT for HAART in Jailed Drug Users / AIDS Related Jacqueline Tulsky, MD Division of HIV, ID and Global Medicine
Enfuvirtide Intensification for Multi-Drug Resistant HIV Steven Deeks, MD Division of HIV, ID and Global Medicine
Adult AIDS Clinical Trials Unit (AACTU) Diane Havlir, MD Division of HIV, ID and Global Medicine
Enfuvirtide Treatment Intensification in Patients with Multi-Drug Resistant HIV Steven Deeks, MD Division of HIV, ID and Global Medicine
T Regulatory Cells and T Cell Activation in HIV Disease Steven Deeks, MD Division of HIV, ID and Global Medicine
Molecular Epidemiology of Human P. Carinii Pneumonia Laurence Huang, MD Division of HIV, ID and Global Medicine
Gender Effects on HIV Biology Ruth Greenblatt, MD Division of HIV, ID and Global Medicine
HIV Controllers: A Potential Model for HIV Eradication Steven Deeks, MD Division of HIV, ID and Global Medicine
HIV Health Services - Program Database Services Division of HIV, ID and Global Medicine, AIDS Research Institute
Positive Health Access to Service and Treatment (PHAST) Division of HIV, ID and Global Medicine
The Social Context of HIV Post-Exposure Prophylaxis (PEP) Division of HIV, ID and Global Medicine
Positive Health Access to Service and Treatment (PHAST) Division of HIV, ID and Global Medicine
San Francisco National Clinical Trial Center, ESPIRIT Steven Deeks, MD Division of HIV, ID and Global Medicine
Ryan White Title IV Program: Integrated Family Services Network / AIDS-related Division of HIV, ID and Global Medicine, AIDS Research Institute
HIV Treatment Training for Clinical Setting Division of HIV, ID and Global Medicine, AIDS Research Institute
Valganciclovir to Reduce T Cell Activation in HIV Infection Peter Hunt, MD Division of HIV, ID and Global Medicine
Therapeutic Strategies for HIV Disease Diane Havlir, MD Division of HIV, ID and Global Medicine
Outpatient Services Ward 86 Division of HIV, ID and Global Medicine, AIDS Research Institute
A Probe to Evaluate the Safety, Tolerability & Immunogenicity of the MRK Adenovirus Serotype 5 Vector Human Immunodeficiency Virus Type 1 gag Vaccine in HIV-1 Infected Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Training in HIV Primary Care - Uganda Clinicians Diane Havlir, MD Division of HIV, ID and Global Medicine
Abbott Preceptorship Division of HIV, ID and Global Medicine, AIDS Research Institute
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane Havlir, MD Division of HIV, ID and Global Medicine
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS Laurence Huang, MD Division of HIV, ID and Global Medicine
Elite Controllers Steven Deeks, MD Division of HIV, ID and Global Medicine
A phase III trial to investigate the efficacy, tolerability & safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected OBR in HIV-1 infected subjects w/ limited to no treatment options Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts (SILCAAT) James Kahn, MD, MPH IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
UCSF-FIND Uganda Project Laurence Huang, MD Division of HIV, ID and Global Medicine
Ward 86 Outpatient Services/Perinatal Services Division of HIV, ID and Global Medicine
Administering Buprenorphine in the San Francisco County Jail Jacqueline Tulsky, MD Division of HIV, ID and Global Medicine
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane Havlir, MD Division of HIV, ID and Global Medicine
The Influence of Pharmacy-Based Syringe Disposal on Unsafe Syringe Discard Among Injection Drug Users in California Elise Riley, PhD Division of HIV, ID and Global Medicine
Treatment of Acute Hepatitis C Virus in HIV Co-Infection Division of HIV, ID and Global Medicine, AIDS Research Institute
PCP OPW Specimens/Uganda Project Support Laurence Huang, MD Division of HIV, ID and Global Medicine
Long Term Follow-Up of Patients Enrolled in Clinical Trials (#A-9602, A-9604, A-9801) Using Retroviral Gene Based Therapies / AIDS related research Steven Deeks, MD Division of HIV, ID and Global Medicine
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of a Novel CCR5 Antagonist, UK427,857, for the Treatment of Antiretroviral-Experienced HIV-1-Infected Subjects Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane Havlir, MD Division of HIV, ID and Global Medicine
Chronic Care HIV/AIDS Multi-Disciplinary Program (CCHAMP) Division of HIV, ID and Global Medicine
Tibotec TMC125-C214: Early Access of TMC125 in Combination with Other Antiretrovirals in Treatment-Experienced HIV-1 Infected Subjects with Limited Treatment 0ptions Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
She's Living Positive Health Fair Division of HIV, ID and Global Medicine
The Determinants of T Cell Activation in HIV Infection Peter Hunt, MD Division of HIV, ID and Global Medicine
Ward 86 Outpatient Services/Perinatal Services Division of HIV, ID and Global Medicine
Targeting Acute HIV Christopher Pilcher, MD Division of HIV, ID and Global Medicine
Training in HIV Translational Research Diane Havlir, MD Division of HIV, ID and Global Medicine
Atripla Adherence and Resistance Relationships [I] Steven Deeks, MD Division of HIV, ID and Global Medicine
Atripla Adherence and Resistance Relationships [II] Steven Deeks, MD Division of HIV, ID and Global Medicine
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Diane Havlir, MD Division of HIV, ID and Global Medicine
Raltegravir Intensification in Antiretroviral-Treated Patients Exhibiting a Suboptimal CD4+T Cell Response Steven Deeks, MD Division of HIV, ID and Global Medicine
Clinical Studies of Interactions Between HIV and Malaria Diane Havlir, MD Division of HIV, ID and Global Medicine
Entecavir Intensification for HIV-HBV Coinfected subjects with persistent HBV viremia Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Chronic Care HIV/AIDS Multidisciplinary Program (CCHAMP) Division of HIV, ID and Global Medicine, AIDS Research Institute
Positive Health Access to Services and Treatment (PHAST) Division of HIV, ID and Global Medicine
Innate Immune Response Genetics and T cell Activation in Treated HIV Infection Peter Hunt, MD Division of HIV, ID and Global Medicine
Innate Effector Function and HIV-1 Control Steven Deeks, MD Division of HIV, ID and Global Medicine
HIV Incidence Testing in Hair Christopher Pilcher, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
International Network for Strategic Initiatives in Global HIV Trials/ ICR INSIGHT Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Master Agreement: International Network for Strategic Initiatives in Global HIV Trials/ICR INSIGHT Steven Deeks, MD Division of HIV, ID and Global Medicine
Task Order # 7: Supplement to SSS A5254 Diane Havlir, MD Division of HIV, ID and Global Medicine
Task Order # 9: Supplement to SSS A5272 Diane Havlir, MD Division of HIV, ID and Global Medicine
Task Order Supplement to A5267 Diane Havlir, MD Division of HIV, ID and Global Medicine
Task Order # 6: Supplement to SSS A5257 Diane Havlir, MD Division of HIV, ID and Global Medicine
Inflammatory and Clinical Consequences of Low-Level Viremia in HIV-1 Infected Patients Division of HIV, ID and Global Medicine
Stored Blood Specimens Division of HIV, ID and Global Medicine
HIV Entry Inhibitors: A New Therapeutic Option Steven Deeks, MD Division of HIV, ID and Global Medicine
The Impact of Food Insecurity on HIV Outcomes and Sexual Risk Behavior in Uganda Sheri Weiser, MD Division of HIV, ID and Global Medicine
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD Division of HIV, ID and Global Medicine
HIV and Lung Complications in the ART Era: Focus on Obstructive Lung Disease Laurence Huang, MD Division of HIV, ID and Global Medicine
HPV Epidemiology and Response to Screening (HEARTS) Elise Riley, PhD Division of HIV, ID and Global Medicine
FIND Xpert MTB assay collaboration at Mulago Hospital Laurence Huang, MD Division of HIV, ID and Global Medicine
TO#5 ACTG-Clinical Research Site - Community Health Promoter Position Diane Havlir, MD Division of HIV, ID and Global Medicine
UCSF/Ragon Collaboration on HIV "Elite" Controllers Steven Deeks, MD Division of HIV, ID and Global Medicine
Sexual Harm Reduction for HIV+ Gay Men (Prevention with Positives) Division of HIV, ID and Global Medicine, AIDS Research Institute
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane Havlir, MD Division of HIV, ID and Global Medicine
HIV Emergence of Drug Resistance Division of HIV, ID and Global Medicine
Family Service Networks - Centers of Excellence Division of HIV, ID and Global Medicine, AIDS Research Institute
Food Insecurity: A Key Structural Barrier to HIV/AIDS Care Sheri Weiser, MD Division of HIV, ID and Global Medicine
Treating HIV-Infected Elite Controllers as a Model of HIV Remission Division of HIV, ID and Global Medicine
Inflammation, T Cell Senescence, and Mortality in Treated HIV Infection Peter Hunt, MD Division of HIV, ID and Global Medicine
Preventing the Establishment of Enfuvirtide-Resistance in the Latent Reservoir Steven Deeks, MD Division of HIV, ID and Global Medicine
Virologic and Host Factors Contributing to HIV Control in Elite Controllers Division of HIV, ID and Global Medicine
AIDS Clinical Trials Network (ACTG) -- Peter Hunt Task Order Peter Hunt, MD Division of HIV, ID and Global Medicine
AIDS Clinical Trials Group (ACTG) TTSG Services Diane Havlir, MD Division of HIV, ID and Global Medicine
Cepheid 077B-C: Evaluation of the Xpert® MTB/RIF Assay Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
AIDS Clinical Trials Group (ACTG) Community Health Promoter Diane Havlir, MD Division of HIV, ID and Global Medicine
Supplement to ATCG A5254: Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load Diane Havlir, MD Division of HIV, ID and Global Medicine
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Diane Havlir, MD Division of HIV, ID and Global Medicine
AIDS Research and Services at SFGH Diane Havlir, MD Division of HIV, ID and Global Medicine
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease(l)) Laurence Huang, MD Division of HIV, ID and Global Medicine
Metabolic Substudy of A5257, CIMT/FMD Repeat Scans (ACTG A5260s:) Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Disulfiram to Accelerate Decay in HIV Reservoirs in ART Treated Patients Steven Deeks, MD Division of HIV, ID and Global Medicine
Pfizer A4001027: Observational Phase Extension Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Assessing Antiretroviral Exposure in Diverse Populations Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine
HIV Pathogenesis and Immunity in Viremic Non-Progressors Peter Hunt, MD Division of HIV, ID and Global Medicine
Ryan White Title IV Program: Family Services Network Division of HIV, ID and Global Medicine, AIDS Research Institute
Adherence Improvement & Measurement (AIM) System Division of HIV, ID and Global Medicine
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven Deeks, MD Division of HIV, ID and Global Medicine
HIV-Specific T-cell Responses in Rectal Mucosa Peter Hunt, MD Division of HIV, ID and Global Medicine
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven Deeks, MD Division of HIV, ID and Global Medicine
Hepatitis C Co-infection Clinic: A to T (Acute to Transplant) Division of HIV, ID and Global Medicine
Neurological AIDS Research Consortium Diane Havlir, MD Division of HIV, ID and Global Medicine
Administration of an ACE-Inhibitor to Decrease the Latent Reservoir Division of HIV, ID and Global Medicine
Study of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Who Have Chronic HCV-1/HIV-1 Co-Infection and Are Treatment-Naïve for Hepatitis C Division of HIV, ID and Global Medicine
Immunologic Determinants of CD4+ T Cell Recovery in Treated HIV+ Africans Peter Hunt, MD Division of HIV, ID and Global Medicine
Characterizing the Role of Immune Activation in HIV Persistence Steven Deeks, MD Division of HIV, ID and Global Medicine
The Impact of Food Insecurity on HIV Outcomes and Sexual Risk Behavior in Uganda Sheri Weiser, MD Division of HIV, ID and Global Medicine
Task Order Agreement No. CRB-DCR01-S-09-00325 Diane Havlir, MD Division of HIV, ID and Global Medicine
Mesalamine to Reduce T Cell Activation in HIV Infection Peter Hunt, MD Division of HIV, ID and Global Medicine
Study of Three NNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive HIV-1-Infected Volunteers (ACTG A5257) Diane Havlir, MD Division of HIV, ID and Global Medicine
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy of A5257 (ACTG A5260s) Diane Havlir, MD Division of HIV, ID and Global Medicine
Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects (ATCG A5262) Diane Havlir, MD Division of HIV, ID and Global Medicine
Task Order A5280: A Prospective, Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART) Diane Havlir, MD Division of HIV, ID and Global Medicine
AIDS Clinical Trials Network (ACTG)-Deeks (Co-Vice Chair) A5296 Steven Deeks, MD Division of HIV, ID and Global Medicine
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy (ACTG) A5260s Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease (ll) Laurence Huang, MD Division of HIV, ID and Global Medicine
Effects of Housing and HIV on Risk Behavior and Victimization of Indigent Women Elise Riley, PhD Division of HIV, ID and Global Medicine
AIDS Research and Services at SF General Hospital Diane Havlir, MD Division of HIV, ID and Global Medicine
Treating HIV-infected Elite Controllers as a Model of HIV Remission Steven Deeks, MD Division of HIV, ID and Global Medicine
Wave 80 Fingerstick Pilot Study Christopher Pilcher, MD Division of HIV, ID and Global Medicine
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (I) Diane Havlir, MD Division of HIV, ID and Global Medicine
Tobira 652-2-202 Pre-Clinical Trial Cost Agreement Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Productive and Latent HIV Infection in Gut Mucosal Reservoirs Diane Havlir, MD Division of HIV, ID and Global Medicine
Patient-Oriented Research and Mentoring in Pneumocystis Laurence Huang, MD Division of HIV, ID and Global Medicine
Task Order: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Steven Deeks, MD Division of HIV, ID and Global Medicine
Short-Term Disulfiram Administration to Reverse Latent HIV Infection Steven Deeks, MD Division of HIV, ID and Global Medicine
HIV Persistence after Successful CCR5-Depleted Stem Cell Transplantation Steven Deeks, MD Division of HIV, ID and Global Medicine
Exploring the Bidirectional Relationship between Food Security and HIV Treatment Outcomes in a Rural Ugandan Cohort Sheri Weiser, MD Division of HIV, ID and Global Medicine
Darpun Sachdev mentored participation in HIV Clinical Trials Division of HIV, ID and Global Medicine, AIDS Research Institute
EraMune Project Steven Deeks, MD Division of HIV, ID and Global Medicine
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services Diane Havlir, MD Division of HIV, ID and Global Medicine
AIDS Clinical Trials Network (ACTG)- Peter Hunt Task Order Peter Hunt, MD Division of HIV, ID and Global Medicine
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects Diane Havlir, MD Division of HIV, ID and Global Medicine
KAM Training Division of HIV, ID and Global Medicine
ACTG, AIDS Clinical Trials Research Group - A5289 and A5255 Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 Diane Havlir, MD Division of HIV, ID and Global Medicine
HIV Specific T-Cell Responses in Rectal Mucosa Steven Deeks, MD Division of HIV, ID and Global Medicine
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa Peter Hunt, MD Division of HIV, ID and Global Medicine
VX11-950-115 An Open Label, Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1) Division of HIV, ID and Global Medicine
Treating HIV-Infected Elite Controllers as a Model of HIV Remission Division of HIV, ID and Global Medicine
UCSF HIV Clinical Trials Unit Diane Havlir, MD Division of HIV, ID and Global Medicine
Identifying and Targeting HIV Persistence in T Cell Subsets during ART Steven Deeks, MD Division of HIV, ID and Global Medicine
Impact of Parasitemia on the Development of Cellular Immune Responses to Malaria Division of HIV, ID and Global Medicine
Developing a Mentoring Network of Diverse Mental Health Professionals Utilizing the CNICS Platform Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine
Effects of CCR5 - delta-32 Heterozygosity on the HIV-1 Reservoir Steven Deeks, MD Division of HIV, ID and Global Medicine
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Uganda (II) Diane Havlir, MD Division of HIV, ID and Global Medicine
Early Mortality in HIV-Infected Patients Starting Antiretroviral Therapy in Africa IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Core B: Specimen Repository Core Steven Deeks, MD Division of HIV, ID and Global Medicine
IDO-induced Tryptophan Catabolism and Mortality in Treated HIV-infected Africans Peter Hunt, MD Division of HIV, ID and Global Medicine
Exploring the Impact of Urban Gardens on Food Insecurity and Health of Low Income Californians: A Community Research Partnership Sheri Weiser, MD Division of HIV, ID and Global Medicine
A Phase 2, Open-Label Study of Daclatasvir (BMS-790052) and TMC435 in Combination With or Without Ribavirin (RBV) For Treatment-Naive Subjects or Null Responders to Prior Peginterferon Alfa (PegIFN)/RBV Therapy with Genotype 1 Chronic Hepatitis C Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Task Order A5303: Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naive Patients Infected with R5-Tropic HIV-1 Diane Havlir, MD Division of HIV, ID and Global Medicine
Host Genetic Predictors of IDO-induced Tryptophan Catabolism Among HIV-Infected Ugandans Maintaining Treatment-Mediated Viral Suppression Sulggi Lee, MD Center for AIDS Research (CFAR), Division of HIV, ID and Global Medicine
CFAR Network (CNICS) Research Platform: Channeling Bias Study IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Gilead GS-US-236-0102 Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (III) Diane Havlir, MD Division of HIV, ID and Global Medicine
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD Division of HIV, ID and Global Medicine
Development of Specimen Repository and Evaluation of Assays for Identification of Recent HIV Infection Christopher Pilcher, MD Division of HIV, ID and Global Medicine
High Throughput Measurement of Envelope Gene Diversity for an HIV Incidence Assay Christopher Pilcher, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Feasibility of a Point-Of-Care CD4+ Test Division of HIV, ID and Global Medicine
Epigenetic Regulation of HIV Latency Steven Deeks, MD Division of HIV, ID and Global Medicine
Targeted Treatment of Early Cryptococcal Infection in HIV-infected Patients Division of HIV, ID and Global Medicine
Performance Evaluation of the Bio-Rad Geenius HIV-1/2 Supplemental Assay Christopher Pilcher, MD Division of HIV, ID and Global Medicine
DAIDS A5298 Study: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Therapeutic Strategies for HIV Disease Diane Havlir, MD Division of HIV, ID and Global Medicine
Study of BMS-790052 plus Peg-Interferon alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with HIV and HCV Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Capacity Based Assistance (CBA) for High Impact HIV Prevention to Health Departments in the United States Division of HIV, ID and Global Medicine
Impact of Sex-Based Differences on HIV Reservoir Size and Immune Activation Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Health Qual Impact Evaluation (HQIE) IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
CHRP for Integrating HIV and Geriatric for People Living with HIV 50 and Over Division of HIV, ID and Global Medicine
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START) Diane Havlir, MD Division of HIV, ID and Global Medicine
Administration of an ACE Inhibitor to Improve Endothelial Function in Treated, HIV-infected Individuals Division of HIV, ID and Global Medicine
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial) Laurence Huang, MD Division of HIV, ID and Global Medicine
Gender-specific Differences Affecting Reactivation of Latent HIV in Treated Patients Steven Deeks, MD Division of HIV, ID and Global Medicine
Continuum of HIV Prevention Care Services Division of HIV, ID and Global Medicine
Family Services Network - Ryan White HIV/AIDS Program Division of HIV, ID and Global Medicine
Characterization of the HIV-1 Latent Reservoir in CCR5-Delta 32 Heterozygotes Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) Coinfected Subjects (GS-US-334-0123) Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Identifying and targeting HIV persistence in T Cell subsets during ART Steven Deeks, MD Division of HIV, ID and Global Medicine
ACE-Inhibitors to Decrease Lymphoid Fibrosis and the Size of the Latent Reservoir in Antiretroviral-Treated, HIV-infected Patients: A Randomized, Placebo-Controlled Study Division of HIV, ID and Global Medicine, AIDS Research Institute
Changing Health through Food Support (CHeFS) Pilot Study (POH) Sheri Weiser, MD Division of HIV, ID and Global Medicine
GS_US_342-1139: Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks with Sofosbuvir and Ribavirin for 12 Weeks in Subjects with Chronic Genotype 2 HCV Infecti Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Office of the UN Special Envoy for Tuberculosis Eric Goosby, MD Institute for Global Health Sciences (IGHS), Division of HIV, ID and Global Medicine
Data Collected through the IAVI Early Infection Cohort Study Christopher Pilcher, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
The effects of alcohol on acute HIV associated neurocognitive disorders Christopher Pilcher, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Evaluation of Haiti Quality Improvement of HIV Care IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
ViiV Healthcare A4001098 Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Specimens Related to the MU-UCSF Research Collaboration Laurence Huang, MD Division of HIV, ID and Global Medicine
Immunologic Consequences of Highly Effective Antimalarial Chemoprevention IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Transcriptional alterations in bronchoalveolar lavage fluid during treatment of human tuberculosis. Laurence Huang, MD Division of HIV, ID and Global Medicine
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda Gabriel Chamie, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, Curry International Tuberculosis Center
Geng's work Order fee for Service Agreement / BMS MI A1424-562 Division of HIV, ID and Global Medicine
Positive Health Access to Services and Treatment (PHAST) Division of HIV, ID and Global Medicine
Reactivation of latent HIV using recombinant galectin-9 Division of HIV, ID and Global Medicine, AIDS Research Institute
Positive Health Access to Services and Treatment (PHAST) Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study Laurence Huang, MD Division of HIV, ID and Global Medicine
Training in HIV Translational Research Diane Havlir, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Pathogenesis of Emphysema/Obstruction and the Microbiome (POEM) in HIV Laurence Huang, MD Division of HIV, ID and Global Medicine
HIV Incidence Testing using Multiple Biological Specimens Christopher Pilcher, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
GS-US-183-0130: A Phase 3, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination with Other Antiretroviral Agents in the Treatment of HIV-1 Infected Subjects Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Heals Endowment Fund at the East Bay Community Foundation Diane Havlir, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
A Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 weeks in Subjects with Chronic HCV and HIV-1 Coinfection Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
HIV RNA and/or Antibody Confirmed Positive Plasma Christopher Pilcher, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine, AIDS Research Institute
Pathways from Food Insecurity to Health and Treatment Outcomes in Women with HIV Sheri Weiser, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Differentiated care for improved health systems efficiency and health outcomes in Zambia (Efficient Health) IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Women's Interagency HIV (WIHS-V) S. Weiser Sheri Weiser, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Geng Work Order RTI Health Solutions (Services for RTI/ViiV) IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Hair measures to assess adherence and explain outcomes in an HIV clinical trial Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Effect of low dose methotrexate on endothelial function and inflammation in HIV - A5314 Diane Havlir, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
ACTG A5294: A Prospective, Phase III Open-Label Study of Response-Guided Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 Coadministered with Ribavirin in Adults with Genotype 1 Chronic HCV and HIV Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Impact of HIV-Associated Inflammation on Disease Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Host Factors Influencing HIV Viral Load and Infectivity in Semen Christopher Pilcher, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda Grant Dorsey, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
A Pilot of Intervention to Promote Acute HIV Testing by Ambulatory Care Providers Christopher Pilcher, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Seek, Test, Treat and Retain Strategies Leveraging Mobile Health and Internet-Based Technologies Jacqueline Tulsky, MD Division of HIV, ID and Global Medicine
Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination with Ribavirin and Daclatasvir for Treatment of Chronic HCV Infection with Treatment Naïve Genotypes 1, 2, 3 or 4 in Subjects Coinfected with HIV-1 Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Reducing Failure-to-Initiate ART: Streamlined ART Start Diane Havlir, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Innovative incentive strategies for sustainable HIV testing and linkage to care Gabriel Chamie, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Pathways contributing to racial disparities among HIV clinic cohort patients Sheri Weiser, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, Prevention Science (formerly the Center for AIDS Prevention Studies or CAPS)
Master Agreement: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Steven Deeks, MD Center for AIDS Research (CFAR), Division of HIV, ID and Global Medicine, AIDS Research Institute
Geng Work Order CNICS: Crane R56 MI Packets IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates Diane Havlir, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Quality Improvement Evaluation Center (Q-IEC) IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Capacity Building and Strengthening Implementation of HIV Combination Prevention and Treatment Services IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Antimalarial drugs in Ugandan populations Melissa Conrad, PhD Division of HIV, ID and Global Medicine
The Women's HIV Program at UCSF & Rhodessa Jones Edward Machtinger, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Pathways from Food Insecurity to Health and Treatment Outcomes in Women with HIV, WEISER CONTINUTATION Sheri Weiser, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Transcriptional alternations in bronchoalveolar lavage fluid during treatment of human tuberculosis Laurence Huang, MD Division of HIV, ID and Global Medicine
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus Henry Chambers, MD Division of HIV, ID and Global Medicine
Better Information for Health in Zambia IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Changing Health through Food Support (CHeFS) Program- Expanded Program Sheri Weiser, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, Prevention Science (formerly the Center for AIDS Prevention Studies or CAPS)
AIDS Clinical Trials Group: REPRIEVE Trial Ancillary Study Diane Havlir, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Impact of a novel multicomponent nutrition intervention on cardiovascular disease risk factors among food-insecure adults with HIV in the Dominican Republic Kartika Palar, PhD Division of HIV, ID and Global Medicine
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
ACTG A5335s Specialty Lab Diane Havlir, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa Diane Havlir, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Enhancing Control of HIV by Inhibiting TRAIL Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Phase 1 Train of Na-APR-w and Na-GST-1 Hookworm Vaccine in Brazilian Adults Bryan Greenhouse, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Malaria Serology evaluation Bryan Greenhouse, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Effect of Pitavastatin on Kidney Function in HIV-infected Persons Diane Havlir, MD Division of HIV, ID and Global Medicine
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV Laurence Huang, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter Hunt, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus, Continuation A120553 Henry Chambers, MD Division of HIV, ID and Global Medicine
HIV Clinical Fellowship Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine, AIDS Research Institute
Impact of interferon-alpha inhibition on immune function and viral persistence in HIV disease Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
AIDS Clinical Trials Group Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine, AIDS Research Institute
SEARCH/AIDS Clinical Trial Research Group Diane Havlir, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
AIDS Clinical Trials Group; Protocol Funds Diane Havlir, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
AIDS Clinical Trial Group Network- Protocol Funding Agreement (Core Funding) Diane Havlir, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
The impact of antimalarial resistance on malaria transmission in Uganda Melissa Conrad, PhD Division of HIV, ID and Global Medicine
Discovery of Oxaboroles as New Antimalarial Agents Philip J. Rosenthal, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
A Multi-Centric Evaluation of a Device for Automated Malaria Microscopy (EasyScan Go) Philip J. Rosenthal, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Intervention to reduce drug use and HIV incidence among high PrEP priority partnered YMSM Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine, AIDS Research Institute
Develop and host an open-access web-based database of implementation science research related to the HIV cascade of care IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
HIV-Specific T-Cell Responses in Rectal Mucosa Peter Hunt, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Getting to Zero Coordinator/ SFPHF Diane Havlir, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
HIV Clinical Fellowship 2018 (Fellow May Baca) Susan Coffey, MD Division of HIV, ID and Global Medicine
HIVMA Clinical Fellowship Program (Baca) Susan Coffey, MD Division of HIV, ID and Global Medicine
African American Center of Excellence Division of HIV, ID and Global Medicine
Chronic Care HIV/AIDS Multidisciplinary Program (CCHAMP) Center of Excellence Division of HIV, ID and Global Medicine
Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes Laurence Huang, MD Division of HIV, ID and Global Medicine
Award - Development of a Social Network-enhanced Adherence Intervention for PrEP in Young African Women Catherine Koss, MD Division of HIV, ID and Global Medicine
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Measuring TB Drugs in Hair as a Tool to Monitor Adherence, Exposure and Response Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine
A Pharmacogenomics Study of HIV Latency: The Role of Anti-Programmed Cell Death-1 (PD-1) Signaling Sulggi Lee, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who are on Opiate Substitution Therapy Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Development and Pilot Testing of a Combination Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement among Fisherfolk in Uganda Judith Hahn, PhD, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV, Hahn K24 Judith Hahn, PhD, MD IGHS Faculty Affiliate, Department of Epidemiology and Biostatistics, Division of HIV, ID and Global Medicine
Measuring and Understanding the Impact of Patient Race and Ethnicity on Physician Care in Illinois Janette Tang, MS IGHS: Global Health Education, Division of HIV, ID and Global Medicine
UN Special Envoy for Tuberculosis: Strategic Priorities Eric Goosby, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Treatment to Reduce Inflammation and Improve Immune Recovery Among Older HIV Patients Division of HIV, ID and Global Medicine
Adaptive Strategies for Preventing and Treating Lapses of Retention in Care (AdaPT-R) IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Validation of Existing Ultra-Sensitive Assays for Quantifying HIV Persistence Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Evaluation of Haiti Quality Improvement of HIV Care IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Modeling malaria incidence in Uganda using sentinel site surveillance data​ Bryan Greenhouse, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases Laurence Huang, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Mechanisms and longitudinal effects of HIV-related stigma on women's adherence and outcomes Sheri Weiser, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
PBO Study: Impact of LLINs with and without PBO in Uganda: a cluster-randomised trial - Innovative Vector Control Consortium (IVCC) Grant Dorsey, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Intestinal MAIT Cells in HIV Infection Peter Hunt, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Measuring the Latent reservoir for HIV Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Impact of long-lasting insecticide treated bednets with and without PBO on malaria indicators in Uganda: a cluster randomised trial Grant Dorsey, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
GS-US-382-3961: A Phase 1b, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of GS-9620 in Antiretroviral Treated HIV-1 Infected Controllers Steven Deeks, MD Division of HIV, ID and Global Medicine
Expanded Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in Nigeria Monica Gandhi, MD, MPH IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
ASN100-201: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Single Dose of ASN100 for the Prevention of Staphylococcus aureus Pneumonia in Heavily Colonized, Mechanically Ventilated Subjects Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine
Women's Center of Excellence Division of HIV, ID and Global Medicine
Assessing the preliminary effects of a multisectoral agricultural intervention on the sexual and reproductive health of HIV-affected adolescent girls Sheri Weiser, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Development of a point of care urine tenofovir immunoassay to distinguish adherence versus resistance-based HIV treatment failure Monica Gandhi, MD, MPH IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Combination immune checkpoint blocker inhibition to eliminate HIV latency Steven Deeks, MD Division of HIV, ID and Global Medicine
Programming Long Term Durable HIV-1 Specific T cell Responses Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter Hunt, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
AIDS Clinical Trials Group: REPRIEVE Trial (A5332 and A5333s) Diane Havlir, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study Laurence Huang, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
M14-730 (EXPEDITION-2): A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Human Immunodeficiency Virus-1 (HIV-1) Co-Infection Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Determinants of Functional Immune Defects in Treated HIV Infection and Aging Peter Hunt, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Engagement in Clinical Care for HIV-Infected Individuals Leaving Jail Kim Koester, PhD Division of HIV, ID and Global Medicine
Expanded HIV Testing for Disproportionately Affected Population Division of HIV, ID and Global Medicine
Ward 86 Outpatient Services / Perinatal Services Division of HIV, ID and Global Medicine
Sustainable East Africa Research in Community Health Diane Havlir, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Mentoring patient-oriented research on the health consequences of polydrug use Elise Riley, PhD Division of HIV, ID and Global Medicine, AIDS Research Institute
Family Services Network - Ryan White HIV/AIDS Program Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine
Reducing dietary risks associated with noncommunicable disease IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
IeDEA Consortium East Africa data center IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
UCSF- Kenyan radiology residency training William Dillon, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, Department of Radiology and Biomedical Imaging
Implementation science research on ART delivery in resource limited settings Vivek Jain, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Vulnerable youth, homelessness, and risk behaviors Colette L. Auerswald, MD, MS IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa (PROMOTE) Diane Havlir, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Improving care delivery for people living with HIV, TB and other chronic diseases through diplomacy Michael J. Reid, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Informing interventions to reduce tobacco use among homeless women Elise Riley, PhD Division of HIV, ID and Global Medicine
Epidemiology of vector borne diseases Isabel Rodriguez Barraquer, MD, PhD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Sustainable approaches to care delivery in Uganda Gabriel Chamie, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Identifying barriers to diabetes and HIV co-management in vulnerable populations Kartika Palar, PhD Division of HIV, ID and Global Medicine, AIDS Research Institute
Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine, AIDS Research Institute
Effects of Polydrug Use, Adulterants and HIV on Cardiac Injury in Homeless Women Elise Riley, PhD Division of HIV, ID and Global Medicine
Leveraging social and sexual networks to reach young men with HIV testing and linkage services Gabriel Chamie, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Strategic antiretroviral therapy and HIV testing for youth in rural Africa (SATURN) Diane Havlir, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
AETC National Coordinating Resource Center, Center for HIV Information UCSF S. Coffey Susan Coffey, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Investigating Mechanisms of HIV Persistence in the Gut Peter Hunt, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
R24 for the CFAR-Network for the Integrated Clinical Science, CNICS IGHS Faculty Affiliate, Center for AIDS Research (CFAR), Division of HIV, ID and Global Medicine, AIDS Research Institute
Estimating the burden of arboviruses in Uganda using age-stratified serological data Isabel Rodriguez Barraquer, MD, PhD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Understanding HIV Pre-exposure Prophylaxis Engagement among Women in East Africa Catherine Koss, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Deeks Order CNICS: June 2014-Aug 2016 Steven Deeks, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Sustainable East Africa Research in Community Health (SEARCH) Diane Havlir, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) Diane Havlir, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Updating HCV treatment engagement paradigms for HIV/HCV coinfected patients Elise Riley, PhD Division of HIV, ID and Global Medicine
ACTG, AIDS Clinical Trial Research Group Diane Havlir, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair) Peter Hunt, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
SFBay CTU Diane Havlir, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine
GSK_201585: Phase III, randomized, multicenter, parallel-group, non inferiority, open-label study evaluating the efficacy, safety, & tolerability of switching to long-acting cabotegravir plus long acting rilpivirine from current INI,NNRTI, or PI-based ART Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Mobile technology to extend clinic-based counseling for HIV+s in Uganda Judith Hahn, PhD, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease Sulggi Lee, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
P.falciparum infection dynamics and transmission to inform elimination (INDIE) Bryan Greenhouse, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Delaney AIDS Research Enterprise to Cure HIV Steven Deeks, MD Division of HIV, ID and Global Medicine
GS-US-380-4030: A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Switching from a Regimen of Dolutegravir and Either Emtricitabine/Tenofovir Alafenamide or Emtricitabine/Tenofovir Disoproxil Fumarate to a Fixed Dose Co Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
MK-3682B-037-00A: Phase 3 Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682B (Grazoprevir/Ruzasvir/Uprifosbuvir) in Participants with Chronic Hepatitis C Virus Genotype 3 Infection Anne Luetkemeyer, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Training in HIV Translational Research Diane Havlir, MD IGHS Faculty Affiliate, Center for AIDS Research (CFAR), Division of HIV, ID and Global Medicine, AIDS Research Institute
Multi-Sectoral Agricultural Intervention to Improve Nutrition, Health and Developmental Outcomes of HIV-infected and Affected Children in Western Kenya Sheri Weiser, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Work Order for CNICS Admin Core 5 Years (related to NIH R24 A1067039) IGHS Faculty Affiliate, Center for AIDS Research (CFAR), Division of HIV, ID and Global Medicine, AIDS Research Institute
URBAN ARCH (3/5) Uganda Cohort - TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety, tolerability, and adherence, Hahn U01 Renewal Judith Hahn, PhD, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
RAPID-VL: Optimizing HIV Viral Load Monitoring and Outcomes for High-Risk Populations Vivek Jain, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden Diane Havlir, MD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine, AIDS Research Institute
Hair Extensions;: Using Hair Levels to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral PrEP, the Vaginal Ring, and Injectables Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine
UnMASC: Uganda Malaria Actionable Surveillance in the time of Coronavirus Melawit Tekeste, MS Division of HIV, ID and Global Medicine
HepC/HIV website Susan Coffey, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Therapeutic vaccination and PD-1 blockade in treated HIV disease Steven Deeks, MD Division of HIV, ID and Global Medicine
Integrated Community-based Treatment of HIV and Hypertension in Zambia Monika Roy, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
Mentoring Multidisciplinary Patient-Oriented Research in Engagement in HIV Care IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Mentoring in Patient Oriented Research on Food Insecurity, HIV and Aging, Weiser K24 Sheri Weiser, MD Division of HIV, ID and Global Medicine
Health, Empowerment, and Recovery Services (HERS) Program Edward Machtinger, MD Division of HIV, ID and Global Medicine, AIDS Research Institute
The impact of antimalarials and insecticide resistance on malaria transmission in Uganda Melissa Conrad, PhD Division of HIV, ID and Global Medicine
The impact of antimalarials and insecticide resistance on malaria transmission in Uganda Melissa Conrad, PhD IGHS Faculty Affiliate, Division of HIV, ID and Global Medicine
Leveraging Social Networks to Improve Retention in Care and Viral Suppression Among HIV-infected Youth in East Africa Lillian B. Brown, MD, PhD Division of HIV, ID and Global Medicine
Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP Monica Gandhi, MD, MPH Division of HIV, ID and Global Medicine, AIDS Research Institute
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2) Judith Hahn, PhD, MD Division of HIV, ID and Global Medicine